Beyond Motion FlexCo saved a substantial six-digit sum and at least one year in time-to-market by classifying its hardware as class I instead of class Im or IIa.
Public source
Publisher name
Public post
The MDR is complex and, at first glance, seems tedious. My initial reaction was to avoid it as long as possible and concentrate on pushing our product further. Until I c…
Company
Beyond Motion FlexCo
We democratize health and empower individuals.
- Industry
- Hospitals and Health Care
- Location
- Graz, AT
- Company size
- 2–10 employees
About Beyond Motion FlexCo
We provide real-time support to help users recover faster and maintain long-term health through IoT devices designed to transform home-based training.
See moreLatest activity
Latest activity from Beyond Motion FlexCo
5 signals
Research & Knowledge
Beyond Motion FlexCo contributed to Chapter 18 of the MDR, the MedTech Founder's Regulatory Playbook, on budget and timeline.
Legal & Regulatory
Beyond Motion FlexCo engaged Bernhard Guggenberger as 100% engaged in the regulatory process.
Legal & Regulatory
Beyond Motion FlexCo classified its hardware as class I instead of class Im or IIa to make a decisive difference in development speed, certification cost, and investor story.
Discover more
Similar signals
Similar public activity from other companies.
Legal & Regulatory
smartQare
smartQare's Healthdot achieved a regulatory milestone with the final Technical Documentation review for a Class IIa medical device under the MDR.
Legal & Regulatory
Restimulate Health, Inc.
Restimulate Health, Inc. achieved federal registration for RESTIMULATE, reflecting continued development of a platform focused on advancing rehabilitation, recovery, and human performance.
Legal & Regulatory
Kneu Health
Kneu Health achieved its second FDA clearance for a new standard of neurological care platform bringing active motor, cognitive and behavioural measures and continuous passive monitoring.
Legal & Regulatory
Johnson & Johnson MedTech
Johnson & Johnson MedTech achieved a major milestone where the Temporary MCS with a microaxial flow pump in AMI-STEMI cardiogenic shock is now a Class IIa recommendation in the 2026 ESC Heart Failure Guidelines.
Legal & Regulatory
Band Connect